Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22.41	36.33	26.29	30.78	109.28	52.25
Short-Term Investments	71.29	86.29	99.72	116.14	46.04	71.02
Cash & Short-Term Investments	93.7	122.62	126	146.91	155.32	123.27
Cash Growth	-26.68%	-2.68%	-14.23%	-5.41%	26.00%	35.71%
Accounts Receivable	0.91	2.41	1.78	1.35	0.9	1.31
Other Receivables	0.3	0.3	0.6	-	-	-
Receivables	1.21	2.71	2.38	1.35	0.9	1.31
Prepaid Expenses	2.54	1.98	3.65	2.87	4.45	3.12
Total Current Assets	97.44	127.32	132.03	151.14	160.66	127.7
Property, Plant & Equipment	0.14	4.36	6.09	6.81	8.08	9.33
Long-Term Investments	-	-	6.28	37.36	35.69	-
Other Long-Term Assets	0.13	0.03	-	0.1	0.06	0.04
Total Assets	97.71	131.71	144.4	195.42	204.49	137.08
Accounts Payable	1.01	2.32	3.22	3.52	3.17	2.99
Accrued Expenses	2.88	5.25	7.05	12.51	7.66	6.16
Current Portion of Leases	0.53	0.48	0.43	0.37	0.38	0.39
Current Unearned Revenue	-	7.57	11.79	16.46	-	-
Other Current Liabilities	0.76	-	-	-	-	-
Total Current Liabilities	5.18	15.62	22.49	32.86	11.22	9.54
Long-Term Debt	3.68	4.83	6.95	10.37	16.3	19.55
Long-Term Leases	0.39	0.81	1.34	1.82	2.23	2.59
Long-Term Unearned Revenue	-	2.86	-	6	-	-
Other Long-Term Liabilities	11.05	10.23	7.6	7.53	5.3	3.43
Total Liabilities	20.31	34.34	38.38	58.57	35.05	35.11
Common Stock	1,419	1,410	1,350	1,319	1,287	985.94
Additional Paid-In Capital	83.29	82.05	81.27	72.41	65.49	60.75
Retained Earnings	-1,376	-1,347	-1,277	-1,204	-1,134	-1,046
Comprehensive Income & Other	-48.13	-48.14	-48.42	-50.49	-48.34	-48.17
Total Common Equity	77.4	97.37	106.02	136.85	169.44	-47.44
Shareholders' Equity	77.4	97.37	106.02	136.85	169.44	101.97
Total Liabilities & Equity	97.71	131.71	144.4	195.42	204.49	137.08
Total Debt	4.61	6.12	8.72	12.55	18.91	22.54
Net Cash (Debt)	89.1	116.51	123.57	171.72	172.1	100.73
Net Cash Growth	-28.15%	-5.71%	-28.04%	-0.22%	70.85%	47.09%
Net Cash Per Share	0.47	0.63	0.74	1.14	1.62	1.33
Filing Date Shares Outstanding	192.32	191.48	179.49	162.57	148.64	95.58
Total Common Shares Outstanding	191.95	189.96	169.87	157.46	144.99	89.68
Working Capital	92.26	111.7	109.54	118.28	149.44	118.16
Book Value Per Share	0.40	0.51	0.62	0.87	1.17	-0.53
Tangible Book Value	77.4	97.37	106.02	136.85	169.44	-47.44
Tangible Book Value Per Share	0.40	0.51	0.62	0.87	1.17	-0.53
Machinery	-	7.72	7.98	7.28	6.79	5.99
Leasehold Improvements	-	8.59	8.59	8.59	8.56	8.56

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q